EGM
RKDA icon

Engineers Gate Manager’s Arcadia Biosciences RKDA Stock Holding History

Engineers Gate Manager’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-294
Closed -$12K – 2240
2021
Q4 		$12K Buy
+294
New +$19.2K ﹤0.01% 1956

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Engineers Gate Manager's RKDA Position: Q1 2022 in Review

Engineers Gate Manager sold out of Arcadia Biosciences (RKDA) in Q1 2022, closing a stake of 294 shares — an estimated $12K sold.

Engineers Gate Manager first reported a position in RKDA in Q4 2021 and held it in 1 quarter. The position peaked at $12K in Q4 2021. 25 funds tracked by Wall St. Rank hold RKDA as of Q1 2022.

  • Engineers Gate Manager reported no remaining Arcadia Biosciences position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 294 Arcadia Biosciences shares in Q1 2022, an estimated $12K.
  • Engineers Gate Manager first reported a position in Arcadia Biosciences in Q4 2021 and held it in 1 quarter.
  • Engineers Gate Manager's Arcadia Biosciences position peaked at $12K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.